Biological effects of chitosan and its derivatives

Food Hydrocolloids

Volumn 51, Issue , 2015, Pages 200-216

  Ngo, Dai Hung ^a,b   Vo, Thanh Sang ^a,c   Ngo, Dai Nghiep ^d   Kang, Kyong Hwa ^a   Je, Jae Young ^a   Pham, Hoang Nguyen Duc ^e   Byun, Hee Guk ^f   Kim, Se Kwon ^a  

^a Pukyong National University   (South Korea)

^b THU DAU MOT UNIVERSITY   (Viet Nam)

^c NGUYEN TAT THANH UNIVERSITY   (Viet Nam)

^d UNIVERSITY OF NATURAL SCIENCES   (Viet Nam)

^e Biotechnology Centre of Ho Chi Minh City   (Viet Nam)

^f Gangneung Wonju National University   (South Korea)

Author keywords

Antioxidant; Biological activities; Chitosan derivatives; Chronic diseases; Reactive oxygen species

Indexed keywords

ACETYLATION; ANTIOXIDANTS; BIOACTIVITY; BIOCOMPATIBILITY; DISEASES;

ALKALINES; BIOLOGICAL EFFECTS; BIOMEDICAL INDUSTRY; CHITOOLIGOMER; CHITOSAN DERIVATIVES; CHRONIC DISEASE; DEACETYLATION; FOOD INDUSTRIES; PHARMACEUTICAL INDUSTRY; REACTIVE OXYGEN SPECIES;

CHITOSAN;

EID: 84934982717     PISSN: 0268005X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodhyd.2015.05.023     Document Type: Review

References (128)

1. Aktaş Y., Yemisci M., Andrieux K., Gürsoy R.N., Alonso M.J., Fernandez-Megia E., et al. Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26. Bioconjugate Chemistry 2005, 16:1503-1511.
2. Anraku M., Fujii T., Kondo Y., Kojima E., Hata T., Tabuchi N., et al. Antioxidant properties of high molecular weight dietary chitosan invitro and invivo. Carbohydrate Polymers 2011, 83:501-505.
3. Artan M., Karadeniz F., Karagozlu M.Z., Kim M.M., Kim S.K. Anti-HIV-1 activity of low molecular weight sulfated chitooligosaccharides. Carbohydrate Research 2010, 345:656-662.
4. Bahar B., O'Doherty J.V., Maher S., McMorrow J., Sweeney T. Chitooligosaccharide elicits acute inflammatory cytokine response through AP-1 pathway in human intestinal epithelial-like (Caco-2) cells. Molecular Immunology 2012, 51:283-291.
5. Bogun M., Inzucchi S.E. Inpatient management of diabetes and hyperglycemia. Clinical Therapeutics 2013, 35:724-733.
6. Bruyere O., Pavelka K., Rovati L.C., Gatterová J., Giacovelli G., Olejarová M., et al. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials. Osteoarthritis Cartilage 2008, 16:254-260.
7. Byun H.G., Kim Y.T., Park P.J., Lin X., Kim S.K. Chitooligosaccharides as a novel β-secretase inhibitor. Carbohydrate Polymers 2005, 61:198-202.
8. Chavez-Delgado M.E., Mora-Galindo J., Gomez-Pinedo U., Feria-Velasco A., Castro-Castaneda S., Toral F.A.L.D., et al. Facial nerve regeneration through chitosan prosthesis. Journal of Biomedical Materials Research 2003, 702-711.
9. Chen Q., Liu S.Q., Du Y.M., Peng H., Sun L.P. Carboxymethyl-chitosan protects rabbit chondrocytes from interleukin-1beta-induced apoptosis. European Journal of Pharmacology 2006, 541:1-8.
10. Cho Y.S., Kim S.K., Ahn C.B., Je J.Y. Inhibition of acetylcholinesterase by gallic acid-grafted-chitosans. Carbohydrate Polymers 2011, 84:690-693.
11. Cho E.J., Rahman A., Kim S.W., Baek Y.M., Hwang H.J., Oh J.Y., et al. Chitosan oligosaccharides inhibit adipogenesis in 3T3-L1 adipocytes. Journal of Microbiology and Biotechnology 2008, 18:80-87.
12. Cho Y., Shi R., Borgens R.B. Chitosan nanoparticle-based neuronal membrane sealing and neuroprotection following acrolein-induced cell injury. Journal of Biological Engineering 2010, 4:1-11.
13. Chung M.J., Park J.K., Park Y.I. Anti-inflammatory effects of low-molecular weight chitosan oligosaccharides in IgE-antigen complex-stimulated RBL-2H3 cells and asthma model mice. International Immunopharmacology 2012, 12:453-459.
14. Chu S.C., Yang S.F., Lue K.H., Hsieh Y.S., Lee C.Y., Chou M.C., et al. Glucosamine sulfate suppresses the expressions of urokinase plasminogen activator and inhibitor and gelatinases during the early stage of osteoarthritis. Clinica Chimica Acta 2006, 372:167-172.
15. Dai X., Chang P., Zhu Q., Liu W., Sun Y., Zhu S., et al. Chitosan oligosaccharides protect rat primary hippocampal neurons from oligomeric β-amyloid 1-42-induced neurotoxicity. Neuroscience Letters 2013, 554:64-69.
16. Dash M., Chiellini F., Ottenbrite R.M., Chiellini E. Chitosan - a versatile semi-synthetic polymer in biomedical applications. Progress in Polymer Science 2011, 36:981-1014.
17. Dass C.R., Tran T.R., Choong P.F.M. Angiogenesis inhibitor and the need for anti-angiogenic therapetutics. Critical Reviews in Oral Biology and Medicine 2007, 10:927-936.
18. Desai U.R. New antithrombin-based anticoagulants. Medicinal Research Reviews 2004, 24:151-181.
19. Do J.Y., Kwak D.M., Kwon O.D. Antidiabetic effects of high molecular weight chitosan in streptozotocin-induced type 1 diabetic ICR mice. Laboratory Animal Research 2008, 24:311-317.
20. Dou J., Xu Q., Tan C., Wang W., Du Y., Bai X., et al. Effects of chitosan oligosaccharides on neutrophils from glycogen-induced peritonitis mice model. Carbohydrate Polymers 2009, 75:119-124.
21. Eom T.K., Senevirathne M., Kim S.K. Synthesis of phenolic acid conjugated chitooligosaccharides and evaluation of their antioxidant activity. Environmental Toxicology and Pharmacology 2012, 34:519-527.
22. Felson D.T. Glucosamine sulfate might have no effect on pain or structural changes associated with osteoarthritis. Nature Clinical Practice Rheumatology 2008, 4:518-519.
23. Fernandes J.C., Tavaria F.K., Soares J.C., Ramos O.S., Monteiro M.J., Pintado M.E., et al. Antimicrobial effects of chitosans and chitooligosaccharides, upon Staphylococcus aureus and Escherichia coli, in food model systems. Food Microbiology 2008, 25:922-928.
24. Fischer T.H., Bode A.P., Demcheva M., Vournakis J.N. Hemostatic properties of glucosamine-based materials. Journal of Biomedical Materials Research 2007, 80A:167-174.
25. Freier T., Koh H.S., Kazazian K., Shoichet M.S. Controlling cell adhesion and degradation of chitosan films by N-acetylation. Biomaterials 2005, 26:5872-5878.
26. Gingras M., Paradis I., Berthod F. Nerve regeneration in a collagen-chitosan tissue-engineered skin transplanted on nude mice. Biomaterials 2003, 24:1653-1658.
27. Gorzelanny C., Pöppelmann B., Strozyk E., Moerschbacher B.M., Schneider S.W. Specific interaction between chitosan and matrix metalloprotease 2 decreases the invasive activity of human melanoma cells. Biomacromolecules 2007, 8:3035-3040.
28. Gurib-Fakim A. Medicinal plants: traditions of yesterday and drugs of tomorrow. Molecular Aspects of Medicine 2006, 27:1-93.
29. Han K.N., Kwon I.K., Lohakare J.D., Heo S., Chae B.J. Chito-oligosaccharides as an alternative to antimicrobials in improving performance, digestibility and microbial ecology of the gut in weanling pigs. Asian - Australasian Journal of Animal Sciences 2007, 20:556-562.
30. Hanson S.R., Sakariassen K.S. Blood flow and antithrombotic drug effects. American Heart Journal 1998, 135:S132-S145.
31. Huang R., Du Y., Yang J., Fan L. Influence of functional groups on the invitro anticoagulant activity of chitosan sulfate. Carbohydrate Research 2003, 338:483-489.
32. Huang R., Mendis E., Kim S.K. Improvement of ACE inhibitory activity of chitooligosaccharides (COS) by carboxyl modification. Bioorganic and Medicinal Chemistry 2005, 13:3649-3655.
33. Huang R.H., Mendis E., Rajapakse N., Kim S.K. Strong electronic charge as an important factor for anticancer activity of chitooligosaccharides (COS). Life Sciences 2006, 78:2399-2408.
34. Itoh S., Suzuki M., Yamaguchi I., Takakuda K., Kobayashi H., Shinomiya K., et al. Development of a nerve scaffold using a tendon chitosan tube. Artificial Organs 2003, 27:1079-1088.
35. Jauch-Chara K., Oltmanns K.M. Obesity - a neuropsychological disease? Systematic review and neuropsychological model. Progress in Neurobiology 2014, 114:84-101.
36. Je J.Y., Kim E.K., Ahn C.B., Moon S.H., Jeon B.T., Kim B., et al. Sulfated chitooligosaccharides as prolyl endopeptidase inhibitor. International Journal of Biological Macromolecules 2007, 41:529-533.
37. Karadeniz F., Artan M., Kong C.S., Kim S.K. Chitooligosaccharides protect pancreatic β-cells from hydrogen peroxide-induced deterioration. Carbohydrate Polymers 2010, 82:143-147.
38. Karagozlu M.Z., Karadeniz F., Kong C.S., Kim S.K. Aminoethylated chitooligomers and their apoptotic activity on AGS human cancer cells. Carbohydrate Polymers 2012, 87:1383-1389.
39. Karagozlu M.Z., Kim J.A., Karadeniz F., Kong C.S., Kim S.K. Anti-proliferative effect of aminoderivatized chitooligosaccharides on AGS human gastric cancer cells. Process Biochemistry 2010, 45:1523-1528.
40. Katiyar D., Singh B., Lall A.M., Haldar C. Efficacy of chitooligosaccharides for the management of diabetes in alloxan induced mice: a correlative study with antihyperlipidemic and antioxidative activity. European Journal of Pharmaceutical Sciences 2011, 44:534-543.
41. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-223.
42. Kim K.N., Joo E.S., Kim K.I., Kim S.K., Yang H.P., Jeon Y.J. Effect of chitosan oligosaccharides on cholesterol level and antioxidant enzyme activities in hypercholesterolemic rat. Journal of the Korean Society of Food Science and Nutrition 2005, 34:26-41.
43. Kim M.M., Kim S.K. Chitooligosaccharides inhibit activation and expression of matrix metalloproteinase-2 in human dermal fibroblasts. FEBS Letters 2006, 580:2661-2666.
44. Kim M.S., Sung M.J., Seo S.B., Yoo S.J., Lim W.K., Kim H.M. Water-soluble chitosan inhibits the production of pro-inflammatory cytokine in human astrocytoma cells activated by amyloid beta peptide and interleukin-1beta. Neuroscience Letters 2002, 321:105-109.
45. Kondo Y., Nakatani A., Hayashi K., Ito M. Low molecular weight chitosan prevents the pro-gression of low dose streptozotocin-induced slowly progressive diabetes mellitus in mice. Biological and Pharmaceutical Bulletin 2000, 23:1458-1464.
46. Kong C.S., Kim J.A., Ahn B., Byun H.G., Kim S.K. Carboxymethylations of chitosan and chitin inhibit MMP expression and ROS scavenging in human fibrosarcoma cells. Process Biochemistry 2010, 45:179-186.
47. 25-35 in PC12 cells. Bioorganic and Medicinal Chemistry Letters 2009, 19:860-862.
48. Lee S.H., Senevirathne M., Ahn C.B., Kim S.K., Je J.Y. Factors affecting anti-inflammatory effect of chitooligosaccharides in lipopolysaccharides-induced RAW264.7 macrophage cells. Bioorganic and Medicinal Chemistry Letters 2009, 19:6655-6658.
49. Li Y., Liu H., Xu Q.S., Du Y.G., Xu J. Chitosan oligosaccharides block LPS-induced O-GlcNAcylation of NF-κB and endothelial inflammatory response. Carbohydrate Polymers 2014, 99:568-578.
50. Lin Y.C., Liang Y.C., Sheu M.T., Lin Y.C., Hsieh M.S., Chen T.F., et al. Chondroprotective effects of glucosamine involving the p38 MAPK and Akt signaling pathways. Rheumatology International 2008, 28:1009-1016.
51. Liu J.N. Study on the hypolipidemic mechanism of chitosan 2008, (Doctor dissertation), Jiangnan University, Wuxi, China.
52. Liu H.T., He J.L., Li W.M., Yang Z., Wang Y.X., Bai X.F., et al. Chitosan oligosaccharides protect human umbilical vein endothelial cells from hydrogen peroxide-induced apoptosis. Carbohydrate Polymers 2010, 80:1062-1071.
53. Liu H., Huang P., Ma P., Liu Q., Yu C., Du Y. Chitosan oligosaccharides suppress LPS-induced IL-8 expression in human umbilical vein endothelial cells through blockade of p38 and Akt protein kinases. Acta Pharmacologica Sinica 2011, 32:478-486.
54. Liu B., Liu W.S., Han B.Q., Sun Y.Y. Antidiabetic effects of chitooligosaccharides on pancreatic islet cells in streptozotocin-induced diabetic rats. World Journal of Gastroenterology 2007, 13:725-731.
55. Liu H.T., Li W.M., Xu G., Li X.Y., Bai X.F., Wei P., et al. Chitosan oligosaccharides attenuate hydrogen peroxide-induced stress injury in human umbilical vein endothelial cells. Pharmacological Research 2009, 59:167-175.
56. Liu P., Piao X.S., Thacker P.A., Zeng Z.K., Li P.F., Wang D., et al. Chito-oligosaccharide reduces diarrhea incidence and attenuates the immune response of weaned pigs challenged with Escherichia coli K88. Journal of Animal Science 2010, 88:3871-3879.
57. Lu X., Guo H., Zhang Y. Protective effects of sulfated chitooligosaccharides against hydrogen peroxide-induced damage in MIN6 cells. International Journal of Biological Macromolecules 2012, 50:50-58.
58. Lu G.Y., Kong L.J., Sheng B.Y., Wang G., Gong Y.D., Zhang X.F. Degradation of covalently cross-linked carboxymethyl chitosan and its potential application for peripheral nerve regeneration. European Polymer Journal 2007, 43:3807-3818.
59. Mei Y.X., Chen H.X., Zhang J., Zhang X.D., Liang Y.X. Protective effect of chitooligosaccharides against cyclophosphamide-induced immunosuppression in mice. International Journal of Biological Macromolecules 2013, 62:330-335.
60. Mendis E., Kim M.M., Rajapakse N., Kim S.K. Carboxy derivatized glucosamine is a potent inhibitor of matrix metalloproteinase-9 in HT1080 cells. Bioorganic and Medicinal Chemistry Letters 2006, 16:3105-3110.
61. Mochizuki M., Kadoya Y., Wakabayashi Y., Kato K., Okazaki I., Yamada M., et al. Laminin-1 peptide-conjugated chitosan membranes as a novel approach for cell engineering. FASEB Journal 2003, 17:586-605.
62. Mohamed S. Functional foods against metabolic syndrome (obesity, diabetes, hypertension and dyslipidemia) and cardiovasular disease. Trends in Food Science and Technology 2014, 35:114-128.
63. Muzzarelli R.A.A. Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone. Carbohydrate Polymers 2009, 76:167-182.
64. Muzzarelli R.A.A., Stanic V., Ramos V. Enzymatic depolymerization of chitins and chitosans. Methods in Biotechnology: Carbohydrate Biotechnology Protocols 1999, Humana Press, Totowa. C. Bucke (Ed.).
65. Ngo D.N., Kim M.M., Kim S.K. Chitin oligosaccharides inhibit oxidative stress in live cells. Carbohydrate Polymers 2008, 74:228-234.
66. Ngo D.N., Kim M.M., Kim S.K. Protective effects of aminoethyl-chitooligosaccharides against oxidative stress in mouse macrophage RAW 264.7 cells. International Journal of Biological Macromolecules 2012, 50:624-631.
67. Ngo D.N., Lee S.H., Kim M.M., Kim S.K. Production of chitin oligosaccharides with different molecular weights and their antioxidant effect in RAW 264.7 cells. Journal of Functional Foods 2009, 1:188-198.
68. Ngo D.H., Ngo D.N., Vo T.S., Ryu B.M., Ta Q.V., Kim S.K. Protective effects of aminoethyl-chitooligosaccharides against oxidative stress and inflammation in murine microglial BV-2 cells. Carbohydrate Polymers 2012, 88:743-747.
69. Ngo D.N., Qian Z.J., Je J.Y., Kim M.M., Kim S.K. Aminoethyl chitooligosaccharides inhibit the activity of angiotensin converting enzyme. Process Biochemistry 2008, 43:119-123.
70. Ngo D.H., Qian Z.J., Ngo D.N., Vo T.S., Wijesekara I., Kim S.K. Gallyl chitooligosaccharides inhibit intracellular free radical-mediated oxidation. Food Chemistry 2011, 128:974-981.
71. Ngo D.H., Qian Z.J., Vo T.S., Ryu B.M., Ngo D.N., Kim S.K. Antioxidant activity of gallate-chitooligosaccharides in mouse macrophage RAW264.7 cells. Carbohydrate Polymers 2011, 84:1282-1288.
72. Ngo D.H., Wijesekara I., Vo T.S., Ta Q.V., Kim S.K. Marine food-derived functional ingredients as potential antioxidants in the food industry: an overview. Food Research International 2011, 44:523-529.
73. No H.K., Park N.Y., Lee S.H., Hwang H.J., Meyers S.P. Antibacterial activities of chitosans and chitosan oligomers with different molecular weights on spoilage bacteria isolated from tofu. Journal of Food Science 2002, 67:1511-1514.
74. No H.K., Park N.Y., Lee S.H., Meyers S.P. Antibacterial activity of chitosans and chitosan oligomers with different molecular weights. International Journal of Food Microbiology 2002, 74:65-72.
75. Okamura Y., Nomura A., Minami S., Okamoto Y. Effects of chitin/chitosan and their oligomers/monomers on release of type I collagenase from fibroblasts. Biomacromolecules 2005, 6:2382-2384.
76. Pangestuti R., Bak S.S., Kim S.K. Attenuation of pro-inflammatory mediators in LPS-stimulated BV2 microglia by chitooligosaccharides via the MAPK signaling pathway. International Journal of Biological Macromolecules 2011, 49:599-606.
77. Pangestuti R., Kim S.K. Neuroprotective properties of chitosan and its derivatives. Marine Drugs 2010, 8:2117-2128.
78. Park P.J., Ahn C.B., Jeon Y.J., Je J.Y. Renin inhibition activity by chitooligosaccharides. Bioorganic and Medicinal Chemistry Letters 2008, 18:2471-2474.
79. Park P.J., Je J.Y., Jung W.K., Ahn C.B., Kim S.K. Anticoagulant activity of heterochitosans and their oligosaccharide sulfates. European Food Research and Technology 2004, 219:529-533.
80. Park P.J., Je J.Y., Kim S.K. Angiotensin I converting enzyme (ACE) inhibitory activity of hetero-chitooligosaccharides prepared from partially different deacetylated chitosans. Journal of Agricultural and Food Chemistry 2003, 51:4930-4934.
81. Patel M., Mao L., Wu B., VandeVord P.J. GDNF-chitosan blended nerve guides: a functional study. Journal of Tissue Engineering and Regenerative Medicine 2007, 1:360-367.
82. Prashanth H.K.V., Thanranatha R.N. Depolymerized products of chitosan as potent inhibitors of tumor-induced angiogenesis. Biochimica et Biophysica Acta - General Subjects 2005, 1722:22-29.
83. Prashanth H.K.V., Tharanathan R.N. Chitin/chitosan: modifications and their unlimited application potential - an overview. Trends in Food Science and Technology 2007, 18:117-131.
84. Qian Z.J., Eom T.K., Ryu B.M., Kim S.K. Angiotensin I-converting enzyme inhibitory activity of sulfated chitooligosaccharides with different molecular weights. Journal of Chitin and Chitosan 2010, 15:75-79.
85. Qiao Y., Bai X.F., Du Y.G. Chitosan oligosaccharides protect mice from LPS challenge by attenuation of inflammation and oxidative stress. International Immunopharmacology 2011, 11:121-127.
86. Quan H., Zhu F., Han X., Xu Z., Zhao Y., Miao Z. Mechanism of anti-angiogenic activities of chitooligosaccharides may be through inhibiting heparanase activity. Medical Hypotheses 2009, 73:205-206.
87. Rabea E.I., Badawy M.E.T., Stevens C.V., Smagghe G., Steurnaut W. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules 2003, 4:1457-1465.
88. Rajapakse N., Kim M.M., Mendis E., Kim S.K. Inhibition of free radical-mediated oxidation of cellular biomolecules by carboxylated chitooligosaccharides. Bioorganic and Medicinal Chemistry 2007, 15:997-1003.
89. Rajapakse N., Mendis E., Kim M.M., Kim S.K. Sulfated glucosamine inhibits MMP-2 and MMP-9 expressions in human fibrosarcoma cells. Bioorganic and Medicinal Chemistry 2007, 15:4891-4896.
90. Reuter S., Gupta S.C., Chaturvedi M.M., Aggarwal B.B. Oxidative stress, inflammation, and cancer: how are they linked?. Free Radical Biology and Medicine 2010, 49:1603-1616.
91. Ronghua H., Yumin D., Jianhong Y. Preparation and anticoagulant activity of carboxybutyrylated hydroxyethyl chitosan sulfates. Carbohydate Polymers 2003, 51:431-438.
92. Senevirathne M., Ahn C.B., Je J.Y. Hepatoprotective effect of chitooligosaccharides against tert-butylhydroperoxide-induced damage in Chang liver cells. Carbohydrate Polymers 2011, 83:995-1000.
93. Shen K.T., Chen M.H., Chan H.Y., Jeng J.H., Wang Y.J. Inhibitory effects of chitooligosaccharides on tumor growth and metastasis. Food and Chemical Toxicology 2009, 47:1864-1871.
94. Ta Q.V., Kim M.M., Kim S.K. Inhibitory effect of chitooligosaccharides on matrix metalloproteinase-9 in human fibrosarcoma cells (HT1080). Marine Biotechnology 2006, 8:593-599.
95. Tapola N.S., Lyyra M.L., Kolehmainen R.M., Sarkkinen E.S., Schauss A.S. Safety aspects and cholesterol-lowering efficacy of chitosan tablets. The Journal of the American College of Nutrition 2008, 27:22-30.
96. Trinh M.D.L., Dinh M.H., Ngo D.H., Tran D.K., Tran Q.T., Vo T.S., et al. Protection of 4-hydroxybenzyl-chitooligomers against inflammatory responses in Chang liver cells. International Journal of Biological Macromolecules 2014, 66:1-6.
97. 2-induced oxidative stress in Chang liver cells by 4-hydroxybenzyl-chitooligomers. Carbohydrate Polymers 2014, 103:502-509.
98. Valko M., Leibfritz D., Moncol J., Cronin M.T.D., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. The International Journal of Biochemistry and Cell Biology 2007, 39:44-84.
99. Vikhoreva G., Bannikova G., Stolbushkina P., Panov A., Drozd N., Makarovd V., et al. Preparation and anticoagulant activity of a low-molecular-weight sulfated chitosan. Carbohydrate Polymers 2005, 62:327-332.
100. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circulation Research 2003, 92:827-839.
101. Vo T.S., Kim S.K. Potential anti-HIV agents from marine resources: an overview. Marine Drugs 2010, 8:2871-2892.
102. Vo T.S., Kim J.A., Ngo D.H., Kong C.S., Kim S.K. Protective effect of chitosan oligosaccharides against FcεRI-mediated RBL-2H3 mast cell activation. Process Biochemistry 2012, 47:327-330.
103. Vo T.S., Kong C.S., Kim S.K. Inhibitory effects of chitooligosaccharides on degranulation and cytokine generation in rat basophilic leukemia RBL-2H3 cells. Carbohydrate Polymers 2011, 84:649-655.
104. Vo T.S., Ngo D.H., Kim S.K. Potential targets for anti-inflammatory and anti-allergic activities of marine algae: an overview. Inflammation and Allergy - Drug Targets 2012, 11:90-101.
105. Vo T.S., Ngo D.H., Kim S.K. Gallic acid-grafted chitooligosaccharides suppress antigen-induced allergic reactions in RBL-2H3 mast cells. European Journal of Pharmaceutical Sciences 2012, 47:527-533.
106. Vo T.S., Ngo D.H., Ta Q.V., Wijesekara I., Kong C.S., Kim S.K. Protective effect of chitin oligosaccharides against lipopolysaccharide-induced inflammatory response in BV-2 microglia. Cellular Immunology 2012, 277:14-21.
107. Wang J., DeBoer J., DeGroot K. Proliferation and differentiation of MC3T3-E1 cells on calcium phosphate/chitosan coatings. Journal of Dental Research 2008, 87:650-654.
108. Wei X., Chen W., Mao F., Wang Y. Effect of chitooligosaccharides on mice hematopoietic stem/progenitor cells. International Journal of Biological Macromolecules 2013, 54:71-75.
109. Wijesekara I., Kim S.K. Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: prospects in the pharmaceutical industry. Marine Drugs 2010, 8:1080-1093.
110. World Health Organization (WHO) Mental health: Action plan 2013-2020 2013, Geneva.
111. Wu H., Aam B.B., Wang W., Norberg A.L., Sørlie M., Eijsink V.G.H., et al. Inhibition of angiogenesis by chitooligosaccharides with specific degrees of acetylation and polymerization. Carbohydrate Polymers 2012, 89:511-518.
112. Wu H., Yao Z., Bai X., Du Y., Lin B. Anti-angiogenic activities of chitooligosaccharides. Carbohydrate Polymers 2008, 73:105-110.
113. Wu H., Yao Z., Bai X., Du Y., Ma X. Chitooligosaccharides inhibit nitric oxide mediated migration of endothelial cells invitro and tumor angiogenesis invivo. Carbohydrate Polymers 2010, 82:927-932.
114. Xia W., Liu P., Zhang J., Chen J. Biological activities of chitosan and chitooligosaccharides. Food Hydrocolloids 2011, 25:170-179.
115. Xu Q., Dou J., Wei P., Tan C., Yun X., Wu Y., et al. Chitooligosaccharides induce apoptosis of human hepatocellular carcinoma cells via up-regulation of Bax. Carbohydrate Polymers 2008, 71:509-514.
116. Xu Q.S., Ma P., Yu W., Tan C.Y., Liu H.T., Xiong C.N., et al. Chitooligosaccharides protect human embryonic hepatocytes against oxidative stress induced by hydrogen peroxide. Marine Biotechnology 2010, 12:292-298.
117. Yamaguchi I., Itoh S., Suzuki M., Sakane M., Osaka A., Tanaka J. The chitosan prepared from crab tendon: the characterization and the mechanical properties. Biomaterials 2003, 24:2031-2036.
118. Yang J., Cai J., Wu K., Li D., Hu Y., Li G., et al. Preparation, characterization and anticoagulant activity invitro of heparin-like 6-carboxylchitin derivative. International Journal of Biological Macromolecules 2012, 50:1158-1164.
119. Yang L., Chen L., Zeng R., Li C., Qiao R., Hu L., et al. Synthesis, nanosizing and invitro drug release of a novel anti-HIV polymeric prodrug: chitosan-O-isopropyl-5'-O-d4T monophosphate conjugate. Bioorganic and Medicinal Chemistry 2010, 18:117-123.
120. Yang T.C., Chou C.C., Li C.F. Antibacterial activity of N-alkylated disaccharide chitosan derivatives. International Journal of Food Microbiology 2005, 97:237-245.
121. Yang C.M., Ferket P.R., Hong Q.H., Zhou J., Cao G.T., Zhou L., et al. Effect of chito-oligosaccharide on growth performance, intestinal barrier function, intestinal morphology and cecal microflora in weaned pigs. Journal of Animal Science 2012, 90:2671-2676.
122. Yao H.T., Chiang M.T. Effect of chitosan on plasma lipids, hepatic lipid and fecal bile acid in Hamsters. Journal of Food and Drug Analysis 2006, 14:183-189.
123. Yao H.T., Huang S.Y., Chiang M.T. Acomparative study on hypoglycemic and hypocholester-olemic effects of high and low molecular weight chitosan in streptozotocin-induced diabetic rats. Food and Chemical Toxicology 2008, 46:1525-1534.
124. Yoon N.Y., Ngo D.N., Kim S.K. Acetylcholinesterase inhibitory activity of novel chitooligosaccharide derivatives. Carbohydrate Polymers 2009, 78:869-872.
125. Yousef M., Pichyangkura R., Soodvilai S., Chatsudthipong V., Muanprasat C. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action. Pharmacological Research 2012, 66:66-79.
126. Zhang J., Xia W., Liu P., Cheng Q., Tahirou T., Gu W., et al. Chitosan modification and pharmaceutical/biomedical applications. Marine Drugs 2010, 8:1962-1987.
127. Zhong Z., Li P., Xing R., Liu S. Antimicrobial activity of hydroxylbenzenesulfonailides derivatives of chitosan, chitosan sulfates and carboxymethyl chitosan. International Journal of Biological Macromolecules 2009, 45:163-168.
128. Zhou S., Yang Y., Gu X., Ding F. Chitooligosaccharides protect cultured hippocampal neurons against glutamate-induced neurotoxicity. Neuroscience Letters 2008, 444:270-274.